High-risk human papillomavirus (HPV) DNA sequences in metaplastic breast carcinomas of Mexican women

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Herrera Goepfert, Roberto ^a   Vela Chávez, Teresa ^a   Carrillo García, Adela ^b   Lizano Soberón, Marcela ^b   Amador Molina, Alfredo ^b   Oñate Ocaña, Luis F ^a   Hallmann, Rita Sotelo Regil ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Breast carcinoma; Carcinogenesis; Human papillomavirus; Integrins; Metaplastic carcinoma; Polymerase chain reaction; Proteoglycans; Quantitative real time

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; VIRUS DNA;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MASTECTOMY; METAPLASTIC BREAST CARCINOMA; MEXICO; OBSERVATIONAL STUDY; PAPILLOMAVIRUS INFECTION; WART VIRUS;

EID: 84884740823     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-445     Document Type: Article

References (48)

1. Ellis IO, Schnitt SJ, Sastre-Garau X, Bussolati G, Tavassoli FA, Eusebi V, Peterse JL, Mukai K, Tabar L, Jacquemier J, Cornellisse CJ, Sasco AJ, Kaaks R, Pisani P, Goldgar DE, Devilee P, Cleton-Jansen MJ, Borresen-Dale AL, Van't Veer L, Sapino A. Metaplastic Carcinomas. Tumours of the breast and female genital organs 2003, 37-41. France: World Health Organization classification of tumours, Tavassoli FA, Devilee P, Lyon: IARC Press.
2. Pezzi CM, Patel-Parekh L, Cole K, Franko J, Klimberg VS, Bland KMD. And the Breast Disease Site Team. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol 2007, 14:166-173.
3. Tse GM, Tan PH, Putti TC, Lui PCW, Chaiwun B, Law BKB. Metaplastic carcinoma of the breast: a clinicopathological review. J Clin Pathol 2006, 59:1079-1083. 10.1136/jcp.2005.030536, 1861754, 16467167.
4. Gobbi H, Simpson JF, Jensen RA, Olson SJ, Page DL. Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas. Mod Pathol 2003, 16:893-901. 10.1097/01.MP.0000085027.75201.B5, 13679453.
5. Reis-Filho JS, Milanezi F, Steele D, Savage K, Simpson PT, Nesland JM, Pereira EM, Lakhani SR, Schmitt FC. Metaplastic breast carcinomas are basal-like tumours. Histopathology 2006, 49:10-21. 10.1111/j.1365-2559.2006.02467.x, 16842242.
6. Rakha EA, Reis-Filho JS, Ellis IO. Basal-Like breast cancer: a critical review. J Clin Oncol 2008, 26:2568-2581. 10.1200/JCO.2007.13.1748, 18487574.
7. Rakha E, Reis-Filho JS. Basal-like breast carcinoma. From expression profiling to routine practice. Arch Pathol Lab Med 2009, 133:860-868.
8. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez- Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, Van De Rijn M, Perou CM. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004, 10:5367-5374. 10.1158/1078-0432.CCR-04-0220, 15328174.
9. Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LFA, de Jong D, Van de Vijver MJ, Van't Veer LJ, Peterse JL. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 2008, 216:141-150. 10.1002/path.2407, 18720457.
10. Di Lonardo A, Venuti A, Marcante ML. Human papillomavirus in breast cancer. Breast Cancer Res Treat 1992, 21:95-100. 10.1007/BF01836955, 1320958.
11. Grenier J, Soria JC, Mathieu MC, Andre F, Abdelmoula S, Velasco V, Morat L, Besse B, Dunant A, Spielmann M, Delaloge S. Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast. Anticancer Res 2007, 27:547-555.
12. Congreso de la Union Reglamento de la Ley General de Salud en Materia de Investigación para la Salud 1986, Estados Unidos Mexicanos: Diario Oficial de la Federación, Congreso de la Union.
13. Sambrook J, Fritsch E, Maniatis T. Molecular cloning: a laboratory manual 1989, Cold Spring Harbor, NY USA: Cold Spring Harbor Press, 2, 2: 9-16.
14. Resnick R, Cornelissen M, Wright D, Eichniger GH, Fox HS, ter Schegget J, Manos MM. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990, 82:1477-1484. 10.1093/jnci/82.18.1477, 2167986.
15. Snijders P, Van den Brule A, Schrijnemaker H, Snow G, Meijer C, Walboomers JM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 1990, 71:173-181. 10.1099/0022-1317-71-1-173, 2154534.
16. Van den Brule A, Meijer CJL, Bakels V, Kenemans P, Walboomers JM. Rapid detection of human papillomavirus in cervical scrapes by combined general primer mediated and type specific polymerase chain reaction. J Clin Microbiol 1990, 28:2739-2743. 268265, 2177751.
17. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H, Iwamoto A. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 1991, 82:524-531. 10.1111/j.1349-7006.1991.tb01882.x, 1648051.
18. Lizano M, De la Cruz-Hernández E, Carrillo-García A, García-Carrancá A, Ponce de León Rosales S, Dueñas-González A, Hernández-Hernández DM, Mohar A. Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol Oncol 2006, 102:230-235. 10.1016/j.ygyno.2005.12.002, 16427686.
19. Taylor ER, Morgan IM. A novel technique with enhanced detection and quantitation of HPV-16 E1- and E2-mediated DNA replication. Virology 2003, 315:103-109. 10.1016/S0042-6822(03)00588-9, 14592763.
20. Herrera-Goepfert R, Khan NA, Koriyama C, Akiba S, Pérez-Sánchez VM. High- risk human papillomavirus in mammary gland carcinomas and adjacent non- neoplastic tissues of Mexican women. Breast 2011, 20:184-189. 10.1016/j.breast.2010.11.006, 21146410.
21. Thike AA, Chng MJ, Fook-Chong S, Tan PH. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters. Pathology 2001, 33:21-25.
22. Cantú-de León D, Pérez-Montiel D, Nemcova J, Mykyskova I, Turcios E, Villavicencio V, Cetina L, Coronel A, Hes O. Human papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients. BMC Cancer 2009, 9:26. 10.1186/1471-2407-9-26, 2636825, 19161629.
23. de Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R, Sastre- Garau X. No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 2008, 109:55-58. 10.1007/s10549-007-9626-4, 17624590.
24. Lindel K, Forster A, Altermatt HJ, Greiner R, Gruber G. Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast 2007, 16:172-177. 10.1016/j.breast.2006.09.001, 17088061.
25. de Villiers EM, Sandstrom RE, zur Hausen H, Buck CE. Presence of papillomavirus sequences in condylomatous lesions of the mammillae and in invasive carcinoma of the breast. Breast Cancer Res 2005, 7:R1-R11. 1064094, 15642157.
26. Khan NA, Castillo A, Koriyama C, Kijima Y, Umekita Y, Ohi Y, Higashi M, Sagara Y, Yoshinaka H, Tsuji T, Natsugoe S, Douchi T, Eizuru Y, Akiba S. Human papillomavirus detected in female breast carcinomas in Japan. Brit J Cancer 2008, 99:408-414. 10.1038/sj.bjc.6604502, 2527789, 18648364.
27. Zhang D, Zhang Q, Zhou L, Huo L, Zhang Y, Shen Z, Zhu Y. Comparison of prevalence, viral load, physical status and expression of human papillomavirus- 16, -18 and -58 in esophageal and cervical cancer: a case-control study. BMC Cancer 2010, 10:650. 10.1186/1471-2407-10-650, 3001448, 21108842.
28. Tsai JH, Tsai CH, Cheng MH, Lin SJ, Xu FL, Yang CC. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non- cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol 2005, 75:276-281. 10.1002/jmv.20267, 15602723.
29. Heng B, Glenn WK, Ye Y, Tran B, Delprado W, Lutze-Mann L, Whitaker NJ, Lawson JS. Human papilloma virus is associated with breast cancer. Br J Cancer 2009, 101:1345-1350. 10.1038/sj.bjc.6605282, 2737128, 19724278.
30. Damin APS, Karam R, Zettler CG, Caleffi M, Alexandre COP. Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat 2004, 84:131-137. 10.1023/B:BREA.0000018411.89667.0d, 14999143.
31. Cazzaniga M, Gheit T, Casadio C, Khan N, Macis D, Valenti F, Miller MJ, Sylla BS, Akiba S, Bonanni B, Decensi A, Veronesi U, Tommasino M. Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis. Breast Cancer Res Treat 2009, 114:599-605. 10.1007/s10549-008-0040-3, 18465220.
32. Mammas IM, Zaravinos A, Sourvinos G, Myriokefalitakis N, Theodoridou M, Spandidos DA. Can 'high-risk' human papillomaviruses (HPVs) be detected in human breast milk?. Acta Paediatr 2011, 100:705-707. 10.1111/j.1651-2227.2010.02129.x, 21214884.
33. Glenn WK, Whitaker NJ, Lawson JS. High risk human papillomavirus and Epstein Barr virus in human breast milk. BMC Research Notes 2012, 5:477. 10.1186/1756-0500-5-477, 3492016, 22937830.
34. Gumus M, Yumuk PF, Salepci T, Aliustaoglu M, Dane F, Ekenel M, Basaran G, Kaya H, Barisik N, Turhal NS. HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples. J Exp Clin Cancer Res 2006, 25:515-521.
35. Yasmeen A, Bismar TA, Kandouz M, Foulkes WD, Desprez PY, Al Moustafa AE. E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells. Cell Cycle 2007, 6:2038-2042. 10.4161/cc.6.16.4555, 17721085.
36. Antonsson A, Spurr TP, Chen AC, Francis GD, McMillan NA, Saunders NA, Law M, Bennett IC. High prevalence of human papillomaviruses in fresh frozen breast cancer samples. J Med Virol 2011, 83:2157-2163. 10.1002/jmv.22223, 22012724.
37. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010, 363:24-35. 10.1056/NEJMoa0912217, 2943767, 20530316.
38. Miyagi J, Kinjo T, Tsuhako K, Higa M, Iwamasa T, Kamada Y, Hirayasu T. Extremely high Langerhans cell infiltration contributes to the favourable prognosis of HPV-infected squamous cell carcinoma and adenocarcinoma of the lung. Histopathology 2001, 38:355-367. 10.1046/j.1365-2559.2001.01067.x, 11318901.
39. Pao C, Hor J, Yang F, Lin C, Tseng C. Detection of human papillomavirus mRNA and cervical cancer cells in peripheral blood of cervical cancer patients with metastasis. J Clin Oncol 1997, 15:1008-1012.
40. Bodaghi S, Wood LV, Roby G, Ryder C, Steinberg SM, Zheng ZM. Could human papillomaviruses be spread through blood?. J Clin Microbiol 2005, 43:5428-5434. 10.1128/JCM.43.11.5428-5434.2005, 1287818, 16272465.
41. Chen AC, Keleher A, Kedda MA, Spurdle AB, McMillan NA, Antonsson A. Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors. J Med Virol 2009, 81:1792-1796. 10.1002/jmv.21592, 19697401.
42. Baba F, Swartz K, van Buren R, Eickhoff J, Zhang Y, Wolberg W, Friedl A. Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor negative, highly proliferative breast carcinoma subtype. Breast Cancer Res Treat 2006, 98:91-98. 10.1007/s10549-005-9135-2, 16636895.
43. Letian T, Tianyu Z. Cellular receptor binding and entry of human papillomavirus. Virol J 2010, 7:2. 10.1186/1743-422X-7-2, 2820467, 20051141.
44. Korsching E, Jeffrey SS, Meinerz W, Decker T, Boecker W, Buerger H. Basal carcinoma of the breast revisited: an old entity with new interpretations. J Clin Pathol 2008, 61:553-560. 10.1136/jcp.2008.055475, 18326009.
45. Cariati M, Naderi A, Brown JP, Smalley MJ, Pinder SE, Caldas C, Purushotham AD. Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer 2008, 122:298-304. 10.1002/ijc.23103, 17935134.
46. Barbareschi M, Maisonneuve P, Aldovini D, Cangi MG, Pecciarini L, Angelo Mauri F, Veronese S, Caffo O, Lucenti A, Palma PD, Galligioni E, Doglioni C. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer 2003, 98:474-483. 10.1002/cncr.11515, 12879463.
47. Leivonen M, Lundin J, Nordling S, von Boguslawski K, Haglund C. Prognostic value of syndecan-1 expression in breast cancer. Oncology 2004, 67:11-18. 10.1159/000080280, 15459490.
48. Kroupis C, Markou A, Vourlidis N, Dionyssiou-Asteriou A, Lianidou ES. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem 2006, 39:727. 10.1016/j.clinbiochem.2006.03.005, 16780823.